Lactacystin, a specific inhibitor of the proteasome, inhibits human platelet lysosomal cathepsin A-like enzyme

Biochemical and Biophysical Research Communications
H OstrowskaK Worowski

Abstract

Lactacystin, the most specific inhibitor of the proteasome, strongly inhibited at pH 5.5 the activity of human platelet lysosomal cathepsin A-like enzyme. At a concentration as low as 1-5 microM it almost completely decreased the hydrolysis rate of cathepsin A specific substrates: Cbz-Phe-Ala and FA-Phe-Phe. This inhibition was probably due to the lactacystin intermediate beta-lactone formed during 10 min hydrolysis at pH 8.0 since nonhydrolyzed inhibitor did not affect cathepsin A activity. Basing on similarities in the inhibitor sensitivity, pH optimum, and substrate preferences it is suggested that the cathepsin A-like activity may be involved in chymotrypsin-like activity of the proteasome.

References

Jul 15, 1991·Biochemical and Biophysical Research Communications·M YukawaT Mori
Jan 15, 1990·The Biochemical Journal·R W Mason
Aug 15, 1988·Biochemical and Biophysical Research Communications·J J MillerR S Levy
Nov 1, 1969·The Journal of Clinical Investigation·R L Nachman, B Ferris
Feb 20, 1995·Archives of Biochemistry and Biophysics·M E Figueiredo-PereiraS Wilk
Nov 30, 1994·Biochemical and Biophysical Research Communications·A SatakeY Suzuki
Aug 15, 1994·Archives of Biochemistry and Biophysics·A V Pshezhetsky, M Potier
Dec 15, 1993·Thrombosis Research·H W MuellerD Deykin
Jan 1, 1994·Enzyme & Protein·H Ostrowska
Jan 1, 1996·Annual Review of Biochemistry·O CouxA L Goldberg

❮ Previous
Next ❯

Citations

Sep 1, 1999·Proceedings of the National Academy of Sciences of the United States of America·L MengC M Crews
Mar 9, 2002·Journal of Virology·Michael D RobekFrancis V Chisari
Mar 19, 2013·Future Medicinal Chemistry·Sven RufThorsten Sadowski
Jun 30, 2000·Biochemical and Biophysical Research Communications·J Y KimC G Yoo
Feb 4, 2014·Scientifica·Aldrin V Gomes
May 13, 1999·Proceedings of the National Academy of Sciences of the United States of America·G LoidlL Moroder
Jul 7, 2014·Nature Chemical Biology·Daniel A BachovchinTodd R Golub
Jun 19, 2001·Medicinal Research Reviews·J MyungC M Crews
Mar 1, 2006·International Journal of Peptide Research and Therapeutics·Carlos García-Echeverría
Jun 27, 2008·Parasitology Research·Josiane CardosoMarco A Krieger
Jan 25, 2012·Progress in Neurobiology·F J A DennissenF W van Leeuwen
Dec 16, 2005·Neoplasia : an International Journal for Oncology Research·Robert B ShirleyM Vijay Kumar
Jan 8, 2015·The Journal of General Virology·Shang-Kwei WangChang-Yih Duh
Oct 8, 2003·Hematology·Laura MagillAlexandra E Irvine
Mar 4, 2008·Cellular & Molecular Biology Letters·Halina Ostrowska
Dec 2, 2004·Biochimica Et Biophysica Acta·Michael Groll, Robert Huber
Aug 22, 2001·Chemistry & Biology·A F Kisselev, A L Goldberg
Apr 18, 2003·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Peter J ElliottWolf-Henning Boehncke
Oct 4, 2000·Journal of Peptide Science : an Official Publication of the European Peptide Society·A J Rivett, R C Gardner
Aug 29, 2002·Nature Cell Biology·Daniela A Bota, Kelvin J A Davies
Nov 2, 2013·Arteriosclerosis, Thrombosis, and Vascular Biology·Nilaksh GuptaThomas M McIntyre
Mar 11, 2005·Expert Review of Anti-infective Therapy·Patricia P Klinger, Ulrich Schubert
Jan 15, 1999·British Journal of Cancer·P B VermeulenL Y Dirix
Sep 9, 2005·Angewandte Chemie·Carmen DrahlErik J Sorensen
Nov 1, 2011·Chemical Communications : Chem Comm·Melissa Ann Gräwert, Michael Groll
Sep 23, 2000·Anti-cancer Drugs·R Z Murray, C Norbury
Jul 11, 2001·The Journal of Biological Chemistry·S RaasiM Groettrup
May 24, 2020·International Journal of Molecular Sciences·Lucia LonghitanoArcangelo Liso
Jun 19, 2012·The Journal of Immunology : Official Journal of the American Association of Immunologists·Lesley M ChapmanCraig N Morrell
Feb 16, 2000·Journal of Peptide Science : an Official Publication of the European Peptide Society·G LoidlL Moroder
Jan 8, 2000·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·H C DrexlerM A Konerding
Jul 5, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·Michael J PalmowskiVincenzo Cerundolo

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.